ELOXX PHARMACEUTICALS, INC. Gain (Loss) on Disposition of Assets
ELOXX PHARMACEUTICALS, INC. (ELOX) reported Gain (Loss) on Disposition of Assets of $0 for the 12-month period ending 2017-06-30, per its 10-K filed 2017-10-13.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2017-10-13
- ELOXX PHARMACEUTICALS, INC. gain (loss) on disposition of assets for fiscal 2017 was $0.00.
- ELOXX PHARMACEUTICALS, INC. gain (loss) on disposition of assets for fiscal 2016 was $0.00.
- ELOXX PHARMACEUTICALS, INC. gain (loss) on disposition of assets for fiscal 2015 was -$8.07K.
- ELOXX PHARMACEUTICALS, INC. gain (loss) on disposition of assets for fiscal 2014 was $0.00.
| Period end | Gain (Loss) on Disposition of Assets 12 month |
|---|---|
| 2017-06-30 | $0.00 10-K · filed 2017-10-13 |
| 2016-06-30 | $0.00 10-K · filed 2017-10-13 |
| 2015-06-30 | -$8.07K 10-K · filed 2017-10-13 |
| 2014-06-30 | $0.00 10-K · filed 2016-10-13 |
| 2013-06-30 | $0.00 10-K · filed 2015-10-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |